AntiParkinson Drugs Global Market Report 2023 – Market Size, Trends, And Market Forecast 2023-2032

The Business Research Company’s AntiParkinson Drugs Global Market Report 2023 – Market Size, Trends, And Market Forecast 2023-2032

LONDON, GREATER LONDON, UK, March 22, 2023 /EINPresswire.com/ -- The Business Research Company’s “AntiParkinson Drugs Global Market Report 2023” is a comprehensive source of information that covers every facet of the antiparkinson drugs market. As per TBRC’s antiparkinson drugs market forecast, the global anti-parkinson drugs market size is expected to grow to $12.37 billion in 2027 at a CAGR of 4.9%.

The increasing geriatric population and surging cases of Parkinson's disease (PD) are projected to drive the demand for the anti-Parkinson drugs market. North America is expected to hold the largest antiparkinson drugs market share. Major players in the antiparkinson drugs market include GlaxoSmithKline PLC., Pfizer, Merck, Novartis, Roche, UCB S.A, Teva Pharmaceuticals, AbbVie Inc., Mylan.

Learn More On The AntiParkinson Drugs Market By Requesting A Free Sample (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=3462&type=smp

Trending AntiParkinson Drugs Market Trend
Eli Lilly and Company, a US-based pharmaceutical company specializing in the discovery, development, manufacturing, and commercialization of human drugs, paid $1.04 billion for Prevail Therapeutics Inc. in December 2020. Through this acquisition, Prevail's portfolio of clinical-stage and preclinical neuroscience assets will serve as the program's foundation, and the acquisition will introduce a new approach to Lilly's drug discovery and development processes. This will allow Lilly to expand its research efforts, launch a gene therapy program, and increase the drug development and commercialization capabilities of Lilly in the field of neurological disorders. Prevail Therapeutics Inc. is a US-based biotechnology company pioneering in the discovery and development of gene therapies for patients with Parkinson's disease and other neurodegenerative disorders.

AntiParkinson Drugs Market Segments
• By Drugs Class: Levodopa/Carbidopa, Dopamine Receptor Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT)-Inhibitors, Anticholinergics, Other Drugs
• By Route of Administration: Oral, Injection, Transdermal
• By Distribution Channel: Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies
• By Geography: The global antiparkinson drugs market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read more on the global antiparkinson drugs market report at:
https://www.thebusinessresearchcompany.com/report/anti-parkinson-drugs-global-market-report

Anti-parkinson drug is a term used to describe the medications that are mostly used to treat Parkinson's disease. They are not psychiatric medications, so they cannot legally be used to treat mental health issues. However, a doctor or psychiatrist may recommend one of these medications in addition to an antipsychotic to lessen some of the antipsychotic's negative effects.

AntiParkinson Drugs Global Market Report 2023 from TBRC covers the following information:
• Market size date for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.

The AntiParkinson Drugs Global Market Report 2023 by The Business Research Company is the most comprehensive report that provides insights on antiparkinson drugs market size, drivers and trends, antiparkinson drugs market major players, competitors' revenues, market positioning, and antiparkinson drugs market growth across geographies. The antiparkinson drugs market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Electrophysiology Devices And Equipment Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/electrophysiology-devices-and-equipment-global-market-report

Neurodegenerative Disorder Therapeutics Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

Brain Monitoring Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/hydroxychloroquines-global-market-report

About The Business Research Company?
The Business Research Company has published over 3000+ detailed industry reports, spanning over 3000+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.